AstraZeneca (AZNL)

12,080.00p
   
  • Change Today:
    -0.52p
  • 52 Week High: 12,372.00
  • 52 Week Low: 9,521.00
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 285,258
  • Market Cap: £152,711m

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
Revenue 45,811.00 44,351.00 37,417.00 26,617.00 24,384.00
Operating Profit/(Loss) 8,193.00 3,757.00 1,056.00 5,162.00 2,924.00
Profit Before Tax 6,899.00 2,501.00 (265.00) 3,916.00 1,548.00
Profit After Tax 5,961.00 3,293.00 115.00 3,144.00 1,227.00
           
Earnings per Share - Basic 384.00¢ 212.00¢ 8.00¢ 244.00¢ 103.00¢
Earnings per Share - Adjusted 384.00¢ 212.00¢ 8.00¢ 244.00¢ 103.00¢
           
Dividend per Share 290.00¢ 290.00¢ 287.00¢ 280.00¢ 280.00¢
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Assets          
Non-Current Assets          
Property, Plant & Equipment 10,502.00 9,449.00 10,171.00 8,917.00 8,335.00
Intangible Assets 58,137.00 59,127.00 62,384.00 32,792.00 32,501.00
Other Non-Current Assets 5,749.00 4,172.00 5,327.00 4,329.00 3,519.00
  76,065.00 73,890.00 79,119.00 47,185.00 45,814.00
Current Assets          
Inventories 5,424.00 4,699.00 8,983.00 4,024.00 3,193.00
Cash at Bank & in Hand 5,840.00 6,166.00 6,329.00 7,832.00 5,369.00
Other Current Assets 116.00 87.00 556.00 666.00 391.00
  25,054.00 22,443.00 26,244.00 19,544.00 15,563.00
           
Other Assets n/a 150.00 n/a n/a n/a
Total Assets 101,119.00 96,483.00 105,363.00 66,729.00 61,377.00
Current Liabilities          
Borrowings 5,400.00 5,542.00 1,893.00 2,386.00 2,010.00
Other Current Liabilities 25,142.00 20,751.00 20,701.00 17,921.00 16,107.00
           
Current Liabilities 30,542.00 26,293.00 22,594.00 20,307.00 18,117.00
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Borrowings 23,222.00 23,690.00 28,888.00 17,994.00 16,217.00
Other Non-Current Liabilities 4,218.00 5,602.00 7,432.00 9,288.00 9,116.00
Non-Current Liabilities 31,411.00 33,132.00 43,482.00 30,784.00 28,664.00
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 61,953.00 59,425.00 66,076.00 51,091.00 46,781.00
           
Net Assets 39,166.00 37,058.00 39,287.00 15,638.00 14,596.00
           
Shareholders Funds 39,143.00 37,037.00 39,268.00 15,622.00 13,127.00
           
Minority Interests/Other Equity 23.00 21.00 19.00 16.00 1,469.00
Total Equity 39,166.00 37,058.00 39,287.00 15,638.00 14,596.00
Cash Flow 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Net Cash Flow From Operating Activities 10,345.00 9,808.00 5,963.00 4,799.00 2,969.00
Net Cash Flow from Investing Activities (4,064.00) (2,960.00) (11,058.00) (285.00) (657.00)
Net Cash Flow from Financing Activities (6,567.00) (6,823.00) 3,649.00 (2,203.00) (1,765.00)
Net Increase/Decrease In Cash (286.00) 25.00 (1,446.00) 2,311.00 547.00
Ratios - based on IFRS 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
PE Ratio - Adjusted 35.0 67.3 1,374.1 38.2 93.7
PEG - Adjusted 0.4 0.0 n/a 0.3 n/a
Earnings per Share Growth - Adjusted 81% 2,550% -97% 137% -39%
Dividend Cover 1.32 0.73 0.03 0.87 0.37
Revenue per Share 2,957.46¢ 2,865.05¢ 26.64¢ 2,028.73¢ 1,874.25¢
Pre-Tax Profit per Share 445.38¢ 161.56¢ (0.19¢) 298.48¢ 118.98¢
Operating Margin 17.88% 8.47% 2.82% 19.39% 11.99%
Return on Capital Employed 60.06% 34.10% 0.07% 76.32% 76.87%
           
Dividend Yield 2.2% 2.0% 2.6% 3.0% 2.9%
Dividend per Share Growth n/a 1.05% 2.50% n/a n/a
Operating Cash Flow per Share 667.85¢ 633.59¢ 420.52¢ 365.78¢ 228.21¢
Cash Incr/Decr per Share (18.46¢) 1.61¢ (1.03¢) 176.14¢ 42.05¢
Net Asset Value per Share (exc. Intangibles) (1,224.73¢) (1,425.65¢) (1,628.84¢) (1,307.47¢) (1,376.25¢)
Net Gearing 58.20% 62.28% 62.27% 80.32% 97.95%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Top of Page